BeStock  
Stocks › Biotechnology › ACRS

Aclaris Therapeutics ACRS

US equityMarket cap rank #3745Biotechnology
$3.40 −$0.30 (-8.11%)
Pre-market · Oct 8, 9:00 am ET · After hours $3.46 +1.76%
Open$3.60
Prev close$3.70
Day range$3.32 – $3.62
Volume9.00M
Market cap$500.48M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$12.00+252.9% vs. price
  • Buy 100%
Low $10.00Now $3.40Avg $12.00High $16.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $16.00, averaging $11.55.

DateFirmRatingTarget
7 Oct 2026 Piper Sandler BUY $11.00
1 Oct 2026 LifeSci Capital BUY $13.00
1 Sep 2026 CCORF BUY $10.00
31 Aug 2026 Piper Sandler BUY $11.00
10 Aug 2026 H.C. Wainwright BUY $16.00
7 Aug 2026 Piper Sandler BUY $11.00
6 Aug 2026 LifeSci Capital BUY $13.00
6 Aug 2026 Craig-Hallum BUY $10.00
17 Jul 2026 Piper Sandler BUY $11.00
1 Jun 2026 LifeSci Capital BUY $13.00
11 May 2026 Piper Sandler BUY $11.00
11 May 2026 Guggenheim BUY $12.00
11 May 2026 H.C. Wainwright BUY $16.00
8 May 2026 Wedbush BUY $10.00
8 May 2026 Oppenheimer BUY $10.00
7 May 2026 Craig-Hallum BUY $10.00
5 May 2026 Piper Sandler BUY $11.00
4 May 2026 Guggenheim BUY $12.00
30 Apr 2026 Craig-Hallum BUY $10.00
29 Apr 2026 Wedbush BUY $10.00

Discussion

No comments yet — be the first to weigh in on ACRS.

Leave a comment

Scroll to Top